Logo image of XERS

XERIS BIOPHARMA HOLDINGS INC (XERS) Stock Analyst Earnings Estimates

NASDAQ:XERS - Nasdaq - US98422E1038 - Common Stock - Currency: USD

5.07  +0.05 (+1%)

After market: 5.07 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
XERS revenue by date.XERS revenue by date.
110.2M
122.18%
163.914M
48.74%
203.07M
23.89%
274.77M
35.31%
328.77M
19.65%
384.87M
17.06%
443.09M
15.13%
497.86M
12.36%
486.03M
-2.38%
EBITDA
YoY % growth
XERS ebitda by date.XERS ebitda by date.
-59.56M
43.07%
-30.85M
48.20%
-21.021M
31.86%
31.314M
248.97%
33.864M
8.14%
112.92M
233.45%
162.91M
44.27%
184.86M
13.47%
212.66M
15.04%
EBIT
YoY % growth
XERS ebit by date.XERS ebit by date.
-71.8M
32.58%
-44.01M
38.70%
-33.646M
23.55%
7.038M
120.92%
37.689M
435.51%
84.796M
124.99%
153.31M
80.80%
197.68M
28.94%
185.41M
-6.21%
Operating Margin
XERS operating margin by date.XERS operating margin by date.
-65.15%-26.85%-16.57%2.56%11.46%22.03%34.60%39.71%38.15%
EPS
YoY % growth
XERS eps by date.XERS eps by date.
-0.70
53.95%
-0.45
35.71%
-0.38
15.56%
-0.09
76.38%
0.11
225.00%
0.36
220.45%
0.65
81.56%
0.94
43.75%
1.13
20.65%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.03
71.95%
-0.01
95.36%
0.01
125.50%
-0.01
83.00%
Revenue
Q2Q % growth
65.867M
37.04%
71.4M
31.57%
75.582M
25.76%
71.859M
19.53%
EBITDA
Q2Q % growth
6.63M
464.49%
9.282M
372.92%
10.914M
-23.70%
7.14M
13,371.70%
EBIT
Q2Q % growth
357K
104.36%
3.978M
130.85%
6.248M
272.13%
3.111M
200.68%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.06
57.14%
-0.05-0.01-10.30%
Q4 2024
Q2Q % growth
-0.03
70.00%
-0.060.0353.56%
Q3 2024
Q2Q % growth
-0.11
-22.22%
-0.09-0.02-19.83%
Q2 2024
Q2Q % growth
-0.10
28.57%
-0.110.018.09%
Q1 2024
Q2Q % growth
-0.14
-16.67%
-0.12-0.02-17.64%
Q4 2023
Q2Q % growth
-0.10 -0.100.00-0.04%
Q3 2023
Q2Q % growth
-0.09
43.75%
-0.120.0323.94%
Q2 2023
Q2Q % growth
-0.14
26.32%
-0.13-0.01-7.65%
Q1 2023
Q2Q % growth
-0.12
52.00%
-0.170.0529.76%
Q4 2022
Q2Q % growth
-0.10
76.19%
-0.160.0637.75%
Q3 2022
Q2Q % growth
-0.16
58.97%
-0.170.014.93%
Q2 2022
Q2Q % growth
-0.19
53.66%
-0.230.0419.01%
Q1 2022
Q2Q % growth
-0.25
16.67%
-0.260.013.50%
Q4 2021
Q2Q % growth
-0.42
-2.44%
-0.25-0.17-68.76%
Q3 2021
Q2Q % growth
-0.39
-11.43%
-0.38-0.01-3.34%
Q2 2021
Q2Q % growth
-0.41
34.92%
-0.31-0.10-33.99%
Q1 2021
Q2Q % growth
-0.30
66.29%
-0.350.0514.13%
Q4 2020
Q2Q % growth
-0.41
66.67%
-0.39-0.02-5.23%
Q3 2020
Q2Q % growth
-0.35
71.31%
-0.530.1833.76%
Q2 2020
Q2Q % growth
-0.63
50.78%
-0.750.1215.62%
Q1 2020
Q2Q % growth
-0.89
16.82%
-0.910.021.74%
Q4 2019
Q2Q % growth
-1.23 -1.16-0.07-6.34%
Q3 2019
Q2Q % growth
-1.22 -1.250.032.56%
Q2 2019
Q2Q % growth
-1.28 -0.96-0.32-33.50%
Q1 2019
Q2Q % growth
-1.07 -0.78-0.29-38.03%
XERS Yearly EPS VS EstimatesXERS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
60.119M
47.94%
58.762M1.357M2.31%
Q4 2024
Q2Q % growth
60.099M
35.39%
59.266M833K1.41%
Q3 2024
Q2Q % growth
54.268M
12.31%
52.462M1.806M3.44%
Q2 2024
Q2Q % growth
48.065M
26.46%
46.727M1.338M2.86%
Q1 2024
Q2Q % growth
40.638M
22.42%
42.651M-2.013M-4.72%
Q4 2023
Q2Q % growth
44.39M
33.95%
44.423M-33K-0.07%
Q3 2023
Q2Q % growth
48.32M
62.53%
41.905M6.415M15.31%
Q2 2023
Q2Q % growth
38.008M
50.17%
35.534M2.474M6.96%
Q1 2023
Q2Q % growth
33.196M
50.41%
31.381M1.815M5.78%
Q4 2022
Q2Q % growth
33.14M
54.64%
31.659M1.481M4.68%
Q3 2022
Q2Q % growth
29.73M
168.81%
29.705M25K0.08%
Q2 2022
Q2Q % growth
25.31M
184.06%
26.042M-732K-2.81%
Q1 2022
Q2Q % growth
22.07M
169.15%
24.059M-1.989M-8.27%
Q4 2021
Q2Q % growth
21.43M
198.88%
19.276M2.154M11.17%
Q3 2021
Q2Q % growth
11.06M
17.04%
11.247M-187K-1.66%
Q2 2021
Q2Q % growth
8.91M
338.92%
9.735M-825K-8.47%
Q1 2021
Q2Q % growth
8.2M
358.10%
7.617M583K7.65%
Q4 2020
Q2Q % growth
7.17M
291.80%
8.372M-1.202M-14.36%
Q3 2020
Q2Q % growth
9.45M
2,948.39%
4.568M4.882M106.87%
Q2 2020
Q2Q % growth
2.03M
576.67%
1.899M131K6.90%
Q1 2020
Q2Q % growth
1.79M
616.00%
1.457M333K22.86%
Q4 2019
Q2Q % growth
1.83M 670.548K1.159M172.91%
Q3 2019
Q2Q % growth
310K 51K259K507.84%
Q2 2019
Q2Q % growth
300K 51K249K488.24%
Q1 2019
Q2Q % growth
250K 102K148K145.10%
XERS Yearly Revenue VS EstimatesXERS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-22.22% 21.43% -85.26% -12.35%
Revenue0% 3.07% 0.21% 2.7%